Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gynecology

Free Subscription 08.09.2025 1 Acta Obstet Gynecol Scand 5 Am J Obstet Gynecol 2 BMC Cancer 1 Br J Cancer 1 Cancer 7 Eur J Obstet Gynecol Reprod Biol 4 Fertil Steril 8 Gynecol Oncol 1 Hum Pathol 3 Hum Reprod 14 Int J Gynaecol Obstet 2 J Clin Endocrinol Metab 2 J Clin Oncol 1 JAMA 1 Obstet Gynecol 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. CHMIELEWSKA B, Pegorie C, Jie M, Mehta N, et al
   Impact of hypertensive disorders on disease progression in pregnancies affected by early-onset fetal growth restriction.
   Acta Obstet Gynecol Scand. 2025 Sep 1. doi: 10.1111/aogs.70049.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

2. BOUATTOUR K, Louis-Sylvestre C, Berry R, Levy-Zauberman Y, et al
   Recovery after Low-Impact Laparoscopic Hysterectomy: A Randomized Controlled Clinical Trial.
   Am J Obstet Gynecol. 2025 Sep 1:S0002-9378(25)00647.
   PubMed         Abstract available
   
   
3. KUHR DL, Singh S, Tavella NF, Rosenberg HM, et al
   Spontaneous uterine rupture at 23 weeks' gestation after prior myomectomy.
   Am J Obstet Gynecol. 2025 Sep 1:S0002-9378(25)00646.
   PubMed        
   
   
4. DRUMMOND RF, Seif KE, Higgs AJ, Reece EA, et al
   Diabetes in Pregnancy and Major New Advances in Diabetes Care Using Long and Ultra-Long Acting Insulins.
   Am J Obstet Gynecol. 2025 Aug 29:S0002-9378(25)00645.
   PubMed         Abstract available
   
   
5. ARTHURS AL, Jackson MR, McCULLOUGH D, Scott HS, et al
   Circular RNAs accumulate in aging human placental tissue and in stillbirth, leading to DNA damage and cellular senescence.
   Am J Obstet Gynecol. 2025 Aug 29:S0002-9378(25)00587.
   PubMed         Abstract available
   
   
6. ANDRADE MCR, Yamaguti EMM, Nadai MNDE, Juliato CRT, et al
   Norethisterone for Prolonged Uterine Bleeding Associated with Etonogestrel Implant (IMPLANET): A Randomized Controlled Trial.
   Am J Obstet Gynecol. 2025 Aug 28:S0002-9378(25)00586.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. YANG Q, Han X
   Prognostic value of risk factors in cervical squamous cell carcinoma based on tumour infiltration depth.
   BMC Cancer. 2025;25:1412.
   PubMed         Abstract available
   
   
8. HAN X, Yang L, Nuermanguli R, Wang H, et al
   In-depth evaluation of XPR1 as a new prognostic indicator for endometrial cancer.
   BMC Cancer. 2025;25:1411.
   PubMed         Abstract available
   
   

   
   Br J Cancer

9. MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al
   HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.
   Br J Cancer. 2025;133:665-673.
   PubMed         Abstract available
   
   

   
   Cancer

10. YOSHINO Y, Furusawa A, Nara K, Taguchi A, et al
    Optimizing treatment for platinum-resistant ovarian clear cell carcinoma: Efficacy of gemcitabine and combination therapy with bevacizumab.
    Cancer. 2025;131:e70071.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

11. MARIN MARTINEZ ME, Vaquero Arguello G, Perez Medina T, Calles Sastre LB, et al
    "Combined use of Radiofrequency ablation and hysteroscopy in the treatment of uterine Myomas: An innovative approach".
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114673.
    PubMed         Abstract available
    
    
12. COLLIN-BUND V, Vibert F, Pontvianne M, Boudier E, et al
    Impact of the 2018 French National College of Gynecologists and Obstetricians recommendations for clinical practice on maternal and neonatal morbidity and mortality in cases of premature rupture of membranes before 32 weeks of amenorrhea at the Univer
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114672.
    PubMed         Abstract available
    
    
13. VUPPU DP, Rajanbabu A, Bhati P, Nair IR, et al
    Beyond the number-Age as a prognostic indicator in endometrial cancer.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114664.
    PubMed         Abstract available
    
    
14. LE TK, Pham TD, Le XT, Ho NT, et al
    A retrospective comparison of live birth rate in freeze-all cycles between progestin-primed ovarian stimulation with dydrogesterone and GnRH antagonist protocols.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114682.
    PubMed         Abstract available
    
    
15. SILVA AKS, Bonfim MB, Ferreira LL, Miguel L, et al
    Surgical approaches to prevent vaginal vault prolapse after hysterectomy, and risk factors for vaginal vault prolapse.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114684.
    PubMed         Abstract available
    
    
16. BOGANI G, Lalli L, Casarin J, Ghezzi F, et al
    Ninety-day surgery-related outcomes of laparoscopic hysterectomy, bilateral salpingo-oophorectomy and sentinel node mapping in apparent early-stage endometrial cancer: a secondary analysis of a prospective single-arm study.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114679.
    PubMed         Abstract available
    
    
17. DOMINONI M, Silvestri A, Ferretti VV, Pano MR, et al
    Which is the best surgical approach for endometrial cancer treatment in elderly women? A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2025;314:114680.
    PubMed         Abstract available
    
    

    
    Fertil Steril

18. LEATHERSICH SJ, Martinez SG, Blockeel C, Martinez F, et al
    Factors affecting quality of life in women with diminished ovarian reserve.
    Fertil Steril. 2025 Sep 3:S0015-0282(25)01862.
    PubMed        
    
    
19. LEE I, Dokras A, Alur-Gupta S
    Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease events.
    Fertil Steril. 2025 Sep 2:S0015-0282(25)01857.
    PubMed         Abstract available
    
    
20. WANG H, Gu X, Li T, Niu X, et al
    Effect of collagen scaffold versus intrauterine device on preventing recurrence of intrauterine adhesions: a multicenter randomized controlled trial.
    Fertil Steril. 2025 Sep 2:S0015-0282(25)01859.
    PubMed         Abstract available
    
    
21. KHORSHID A, Monseur B, Bavan B
    Cost-Effectiveness of Single versus Double Embryo Transfer to Gestational Carriers for Male Same-Sex Intended Parents.
    Fertil Steril. 2025 Aug 28:S0015-0282(25)01852.
    PubMed        
    
    

    
    Gynecol Oncol

22. MORTON M, Chalif J, Sciuva J, Fulton J, et al
    The price of delay: Insurance-related treatment delays in patients with gynecologic cancer receiving immunotherapy.
    Gynecol Oncol. 2025;201:144-151.
    PubMed         Abstract available
    
    
23. BRODSKY AL, Welte T, Vuttaradhi VK, Yang X, et al
    Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor models.
    Gynecol Oncol. 2025;201:152-159.
    PubMed         Abstract available
    
    
24. CHIAPPINELLI KB, Christie EL, Padmanabhan A
    Biology of ovarian cancer: Models, microenvironment, and therapeutics: 15th Biennial Rivkin Center Ovarian Cancer Research Symposium.
    Gynecol Oncol. 2025;201:160-163.
    PubMed         Abstract available
    
    
25. REBOUILLAT C, Pomel C, Bourdel N, Mimoun C, et al
    Diagnostic laparoscopy and cytoreduction surgery in ovarian cancer FIGO III-IV: The impact on survival of one-stage versus two-stage sequence.
    Gynecol Oncol. 2025;201:167-175.
    PubMed         Abstract available
    
    
26. LIN Z, Liu Z, Chen J, Gu H, et al
    Novel anatomical concept and standardized technique for single-port Paraaortic lymphadenectomy in gynecological cancers.
    Gynecol Oncol. 2025;201:176-183.
    PubMed         Abstract available
    
    
27. MATSUO K, Enserro DM, Wright JD, Roman LD, et al
    Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.
    Gynecol Oncol. 2025;201:184-194.
    PubMed         Abstract available
    
    
28. ETTORRE VM, Demirkiran C, Bellone S, Hartwich TMP, et al
    Effective preclinical activity of datopotamab deruxtecan (Dato-DXd), an ADC targeting trophoblast cell-surface antigen 2 (TROP2), against primary cervical carcinoma cell lines and xenografts.
    Gynecol Oncol. 2025;201:195-202.
    PubMed         Abstract available
    
    
29. ACKROYD SA, Sudilovsky G, Che Y, Wesevich A, et al
    Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center.
    Gynecol Oncol. 2025;201:203-209.
    PubMed         Abstract available
    
    

    
    Hum Pathol

30. QIN L, Lin W, Huang S, Zheng W, et al
    High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 Mutations: Clinicopathologic characteristics and novel molecular events.
    Hum Pathol. 2025;164:105928.
    PubMed         Abstract available
    
    

    
    Hum Reprod

31. BHAGWAT S, Asadi L, McCarthy R, Ferreira J, et al
    Bacterial vaginosis toxins impair sperm capacitation and fertilization.
    Hum Reprod. 2025 Jul 13:deaf132. doi: 10.1093.
    PubMed         Abstract available
    
    
32. QU R, Liang F, Fan L, Shi R, et al
    Pathogenic variants in DLGAP5 cause female infertility characterized by oocyte maturation arrest and embryonic arrest.
    Hum Reprod. 2025;40:1773-1785.
    PubMed         Abstract available
    
    
33. VERFURDEN ML, Schnecke V, Winning Lehmann E, Rendon Guillen A, et al
    Association between weight loss and reproductive outcomes among women with overweight or obesity: a cohort study using UK real-world data.
    Hum Reprod. 2025;40:1753-1761.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

34. ZORLU U, Ozkavak OO, Serbetci H, Karatas E, et al
    Unraveling preeclampsia: Is the fibrinogen-to-albumin ratio the key to early risk assessment?
    Int J Gynaecol Obstet. 2025 Sep 1. doi: 10.1002/ijgo.70510.
    PubMed         Abstract available
    
    
35. LEWIS JM, Algurjia E, Lumsden MA, Meinhold-Heerlein I, et al
    Image-guided therapies for uterine fibroids.
    Int J Gynaecol Obstet. 2025 Sep 1. doi: 10.1002/ijgo.70493.
    PubMed         Abstract available
    
    
36. MANASYAN A, Jones AV, Xue Y, Kapesa H, et al
    Low syphilis treatment rates and associated birth outcomes in pregnant women with and without HIV in Zambia: A cohort study.
    Int J Gynaecol Obstet. 2025 Sep 3. doi: 10.1002/ijgo.70518.
    PubMed         Abstract available
    
    
37. TYSON NA, Bhuinneain MN, Divakar H, Mauger L, et al
    Elevating and empowering reproductive futures: Pediatric and adolescent gynecology's specialized care across the globe.
    Int J Gynaecol Obstet. 2025 Sep 5. doi: 10.1002/ijgo.70499.
    PubMed         Abstract available
    
    
38. FARINA S, Sabatelli A, Boccia S, Scambia G, et al
    Environment, lifestyle, and cancer in women.
    Int J Gynaecol Obstet. 2025;171 Suppl 1.
    PubMed         Abstract available
    
    
39. KOSKAS M, Crosbie EJ, Fokdal L, McCluggage WG, et al
    Cancer of the corpus uteri: A 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1.
    PubMed         Abstract available
    
    
40. ADAMS TS, Maluleke JC, Cuello MA
    Cancer of the vagina: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1.
    PubMed         Abstract available
    
    
41. OLAWAIYE AB, Cuello MA, Beriwal S, Rogers LJ, et al
    Cancer of the vulva: 2025 update: FIGO Cancer Report 2025.
    Int J Gynaecol Obstet. 2025;171 Suppl 1.
    PubMed         Abstract available
    
    
42. RENZ M, Friedlander M, Berek JS
    Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:6-35.
    PubMed         Abstract available
    
    
43. RUZINDANA K, Anorlu RI
    Global disparities in gynecologic cancer outcomes: A call for action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:210-220.
    PubMed         Abstract available
    
    
44. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:87-108.
    PubMed         Abstract available
    
    
45. CUELLO MA, Gomez-Valenzuela F, Wichmann I, Olawaiye AB, et al
    Global determinants of gynecologic cancer incidence and mortality: A cluster-based analysis with predictive insights.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:147-165.
    PubMed         Abstract available
    
    
46. WILAILAK S, Kengsakul M, Kehoe S
    Strategic approaches for global cervical cancer elimination: An update review and call for national action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:120-128.
    PubMed         Abstract available
    
    
47. YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
    Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

48. 
    Correction to: "Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2025 Sep 3:dgaf494. doi: 10.1210.
    PubMed        
    
    
49. 
    Correction to: "Limiting Premenstrual Endometrial Hypoxia Inducible Factor 2 Alpha May Fine-Tune Endometrial Function at Menstruation".
    J Clin Endocrinol Metab. 2025 Sep 5:dgaf493. doi: 10.1210.
    PubMed        
    
    

    
    J Clin Oncol

50. KONSTANTINOPOULOS PA, Kim JW, Freyer G, Lee JY, et al
    Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation.
    J Clin Oncol. 2025 Jul 23:JCO2500225. doi: 10.1200/JCO-25-00225.
    PubMed         Abstract available
    
    
51. LIU JF, Colombo N, Oza AM, Frenel JS, et al
    ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma.
    J Clin Oncol. 2025;43:2897-2907.
    PubMed         Abstract available
    
    

    
    JAMA

52. ANDERER S
    Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
    PubMed        
    
    

    
    Obstet Gynecol

53. RAY M, Heinsberg LW, McNeil RB, Grobman WA, et al
    Allostatic Load Mediates Associations Between Race and Ethnicity and Hypertensive Disorders of Pregnancy.
    Obstet Gynecol. 2025 Sep 4. doi: 10.1097/AOG.0000000000006062.
    PubMed         Abstract available
    
    

    
    PLoS One

54. SANTANA CH, Souza MFS, Silva L, Souza LDR, et al
    Expression of hormonal receptors and Toll-like receptors in cultured canine uterine explants with pseudoplacentational endometrial hyperplasia and bacterial-elicited endometrial inflammation.
    PLoS One. 2025;20:e0331209.
    PubMed         Abstract available
    
    
55. KIRAN TR, Erdem M, Yildirim E, Inceoglu F, et al
    Vascular imbalance in polycystic ovary syndrome: Insights into endothelial dysfunction.
    PLoS One. 2025;20:e0332030.
    PubMed         Abstract available
    
    
56. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    PubMed         Abstract available
    
    
57. BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al
    Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.
    PLoS One. 2025;20:e0317641.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.